Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.
作者信息
Dhamoon Mandip S, Elkind Mitchell S V
机构信息
Department of Neurology, Columbia University, New York, NY, USA.
出版信息
Circulation. 2010 May 11;121(18):2071-8. doi: 10.1161/CIRCULATIONAHA.109.921072.
Abstract
摘要
相似文献
1
Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.
Circulation. 2010 May 11;121(18):2071-8. doi: 10.1161/CIRCULATIONAHA.109.921072.
2
New guidelines to reduce risk of atherosclerotic cardiovascular disease: implications for stroke prevention in 2014.
Stroke. 2014 Apr;45(4):945-7. doi: 10.1161/STROKEAHA.114.004560. Epub 2014 Feb 20.
3
The USPSTF recommendation statement on coronary heart disease risk assessment.
Ann Intern Med. 2010 Mar 16;152(6):403-4; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00016.
4
The USPSTF recommendation statement on coronary heart disease risk assessment.
Ann Intern Med. 2010 Mar 16;152(6):403; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00015.
5
The USPSTF recommendation statement on coronary heart disease risk assessment.
Ann Intern Med. 2010 Mar 16;152(6):404-5; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00017.
6
The USPSTF recommendation statement on coronary heart disease risk assessment.
Ann Intern Med. 2010 Mar 16;152(6):405; author reply 405-6. doi: 10.7326/0003-4819-152-6-201003160-00018.
7
Therapeutic interventions and success in risk factor control for secondary prevention of stroke.
J Stroke Cerebrovasc Dis. 2009 Nov-Dec;18(6):460-5. doi: 10.1016/j.jstrokecerebrovasdis.2009.01.014.
8
Challenges to the management of high-risk stroke patients with multiple-site occlusive vascular disease.
Cerebrovasc Dis. 2011;31(4):315-21. doi: 10.1159/000322603. Epub 2011 Jan 7.
9
The Potential for Postrandomization Confounding in Randomized Clinical Trials.
JAMA. 2016 Jun 7;315(21):2273-4. doi: 10.1001/jama.2016.3676.
10
Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease.
JACC Cardiovasc Imaging. 2025 Apr;18(4):465-475. doi: 10.1016/j.jcmg.2024.12.008. Epub 2025 Mar 5.
引用本文的文献
1
Incidence of Acute Myocardial Infarction in Patients Presenting With Cerebrovascular Accident in a Tertiary Care Centre in Eastern India.
Cureus. 2022 Sep 10;14(9):e29005. doi: 10.7759/cureus.29005. eCollection 2022 Sep.
2
Cardiovascular Events After Intracerebral Hemorrhage.
Stroke. 2022 Jul;53(7):2131-2141. doi: 10.1161/STROKEAHA.122.036884. Epub 2022 Jun 8.
3
Psychological and social support associations with mortality and cardiovascular disease in middle-aged American Indians: the Strong Heart Study.
Soc Psychiatry Psychiatr Epidemiol. 2022 Jul;57(7):1421-1433. doi: 10.1007/s00127-022-02237-7. Epub 2022 Feb 14.
4
Association between systemic sclerosis and peripheral arterial disease: a nationwide observation retrospective claim records cohort study in Taiwan.
BMJ Open. 2021 Sep 29;11(9):e048149. doi: 10.1136/bmjopen-2020-048149.
5
Coronary Artery Calcium Score Improves the Prediction of Occult Coronary Artery Stenosis in Ischemic Stroke Patients.
J Am Heart Assoc. 2016 Oct 31;5(11):e003770. doi: 10.1161/JAHA.116.003770.
6
Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.
J Am Heart Assoc. 2016 Jul 12;5(7):e003547. doi: 10.1161/JAHA.116.003547.
7
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.
Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S216-28. doi: 10.1007/s00508-016-0993-x.
8
Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50,000 participants.
BMJ Open. 2016 Jan 20;6(1):e009535. doi: 10.1136/bmjopen-2015-009535.
9
Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.
Am J Med Sci. 2014 Aug;348(2):108-14. doi: 10.1097/MAJ.0000000000000292.
10
Authors' reply.
Indian J Endocrinol Metab. 2012 May;16(3):472-3. doi: 10.4103/2230-8210.95720.
本文引用的文献
1
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.
Stroke. 2009 Apr;40(4):1405-9. doi: 10.1161/STROKEAHA.108.534107. Epub 2009 Feb 19.
2
The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.
Am J Cardiol. 2008 Dec 15;102(12):1668-73. doi: 10.1016/j.amjcard.2008.07.060. Epub 2008 Oct 23.
3
4
Telmisartan to prevent recurrent stroke and cardiovascular events.
N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.
5
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
6
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
7
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
8
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
9
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
BMJ. 2007 Jul 21;335(7611):136. doi: 10.1136/bmj.39261.471806.55. Epub 2007 Jul 5.
10
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study.
Stroke. 2007 Jun;38(6):1752-8. doi: 10.1161/STROKEAHA.106.480988. Epub 2007 Apr 12.
Zotero 插件